Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
ID: 350876Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350876

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-048.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovative research in the implementation of genomic information in clinical care across diverse populations. This grant supports small research projects that can be conducted in a short timeframe with limited resources, focusing on enhancing the generalizability of findings and improving health outcomes while addressing barriers to the adoption of genomic medicine. Eligible applicants include various educational and nonprofit institutions, with a maximum budget of $50,000 in direct costs per year and a project duration of up to two years. Interested parties should submit their applications by February 11, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-HG-23-048-Full-Announcement.html
    RFA-HG-23-048.html
    The National Human Genome Research Institute (NHGRI) is soliciting proposals for the "Advancing Genomic Medicine Research" funding opportunity under the R03 Small Grant Program. Aimed at enhancing the implementation of genomic information in clinical care across diverse populations, the initiative seeks to stimulate innovative research on genomic medicine without clinical trials. Proposals should focus on the generalizability of findings beyond specific diseases, facilitating the integration of genomic data, improving health outcomes, and addressing barriers in adoption. Key elements include eligibility for various educational and nonprofit institutions, a maximum budget of $50,000 in direct costs per year, and a total project duration of up to two years. NHGRI encourages applications including previously underrepresented populations in genomic research, and emphasizes the need for stakeholder engagement and robust data sharing as per NIH policies. All applications must adhere strictly to submission guidelines, with deadlines aligned to 5:00 PM local time. Applications will be evaluated on scientific merit, innovation, significance, and the potential for generalizable impact on the field of genomic medicine.
    Similar Opportunities
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that enhance understanding of genomic data applications, assess implementation methods, and identify barriers to health equity, particularly for underrepresented groups. The R03 grant mechanism supports small research projects with a maximum budget of $50,000 per year, with an estimated total funding of approximately $150,000 for two awards in fiscal year 2024. Applications must be submitted electronically by February 12, 2025, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" grant, aimed at stimulating innovative research in the implementation of genomic technologies in clinical care. This funding opportunity emphasizes addressing health disparities and requires applicants to develop a Plan for Enhancing Diverse Perspectives to ensure inclusivity in research teams and participant recruitment. The initiative seeks to explore the value of genomic data in improving clinical outcomes, identify barriers to implementation, and develop effective data-sharing methods, with approximately $2.4 million available for three awards and an additional $700,000 for one award in fiscal year 2024. Applications are due by February 12, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovation in the application of genomic information in clinical care, particularly for populations experiencing health disparities. The initiative seeks to enhance understanding of how to effectively implement and share genomic technologies across diverse communities, including racial and ethnic minorities, underserved rural populations, and sexual and gender minority groups. With an expected total funding of approximately $1.5 million for fiscal year 2024, individual project budgets may reach up to $250,000. Interested applicants must submit their proposals by February 11, 2025, and can find additional details and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" aimed at enhancing the use and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that focus on understanding the implementation of genomic medicine, addressing barriers to access, and developing analytical tools for clinical genomic data, with a strong emphasis on inclusivity for populations experiencing health disparities. The NIH has allocated approximately $2.4 million for three projects, with an additional project funded by the National Cancer Institute, and applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. Interested parties must submit their applications by February 11, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Enhancing Reuse of NHGRI Data Assets (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancing Reuse of NHGRI Data Assets" under the R03 Small Grant Program, aimed at promoting innovative research and secondary analysis projects utilizing genomic datasets from the National Human Genome Research Institute's (NHGRI) AnVIL platform. The initiative seeks to eliminate cost barriers for new users and enhance the utilization of NHGRI datasets, thereby stimulating further discovery in genomics research. Approximately $1 million will be allocated annually for up to seven awards, with each project having a budget limit of $125,000 in direct costs and a maximum project period of two years. Interested applicants must submit their proposals by January 14, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Dental and Craniofacial Research (NIDCR), has announced a funding opportunity for Small Research Grants (R03) aimed at analyzing existing genomic data related to dental, oral, and craniofacial health. This initiative encourages projects that utilize publicly available genomic data and advanced methodologies, focusing on oral health disparities and biological pathways to identify intervention targets. The grant supports projects with budgets up to $200,000 over two years, with applications due by May 7, 2026. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)" aimed at supporting innovative research in computational genomics and data science. This initiative encourages applications that focus on developing novel analytical methodologies, tools, and software that can be broadly applied to enhance human health and disease understanding, with an emphasis on scalable systems for managing complex genomic data. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal colleges, with a maximum budget of $500,000 per year available for projects lasting up to five years. The application submission period opens on January 6, 2025, and closes on September 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.